We organize a strong anti-cancer movement by putting together a close-knit team.
This movement comes laden with a great “ANTICANCER” mission encapsulating philosophy,
values, a corporate culture, ambitions and the development perspectives.
• Transform the Doctor Nona’s patents into medicines for treatment of certain types of oncological diseases. Pharmaceutics and Dermo-cosmetics.
• Continue preclinical and clinical tests for development of medicinal preparations.
• Organize strong movement against the oncology.
• Make our medical products affordable.
• Change the lives of people. Give them hope for future.
• Promote ANTICANCER Mission among the familiar and unfamiliar people and organizations.
• Enable each project participant to state confidently and proudly: “I am participating in development of the cure for cancer! What about you?”
Today, cancer is an epidemic. Cancer is a serious problem, since it is dormant in each of us. Our bodies constantly produce defective cells. This results in tumors. But there is good news too – the early diagnosis made the most of the tumors non-fatal. Today we unite to fight against this menacing disease. We organize a strong anti-cancer movement by putting together a close-knit “ANTICANCER Mission” team.
A team of researchers from the Lenom Clinic led by doctor Nona Kuchina, in collaboration with a Dead Sea Laboratory research team led by professor Tsvi Bentwich, are actively engaged in the creation of a cure for skin cancer.
Proceeds from ANTICANCER Mission project shall be used for:
• Preclinical and clinical tests.
• Development of cream, ointment and food supplement formulas.
• Payment for work of the scientists as per cooperation agreements.
• Publications and participation in International Workshops on skin cancer, improvement of project image around the world.
• Continuation of work with N. N. Blokhin NMRC of oncology intended for reduction of injury of normal tissues during chemotherapy (leukopenia and marrow failure).
• Continuation of halophilic bacterium and Dunaliella studies for restorative treatment after aggressive therapy methods.
• Registration of received medications in distributor countries.
Skin cancer types:
- Squamous Cell carcinoma (SCC)
It is characterized by rapid development and is spread both on surface and to the depth of skin. It can adhere to muscular, bone and cartilaginous tissues. That’s when (!) the pain syndrome appears. In appearance, it is in a form of spots, ulcer or lumps and looks like the cauliflower.
- Basal Cell carcinoma (BCC)
More benign and slow disease progression. Metastasing is rare. It may be: nodular-ulcerous, verrucous, perforate, scarry-atrophic, pigmentary, modular, etc.
Retromuscular (underarm) and pelvic area. It is characterized by slow progression.
It ranks second in cancer related diseases with “lethal outcome”. Pigmented tumor with black, brown or gray circumference.
- Skin cancer metastasis – on lymphatic vessels, with developing lung cancer, gastric cancer, bone, liver, brain, breast, kidney, adrenal carcinoma.
In the USA, over 8.1 billion dollars is spent annually on skin cancer research and treatment. More specifically:
$3.3 billion is spent on melanoma research;
$4.8 billion is spent on other areas of cancer research.
Every year in the United States over 4.3 million cases of basal-cell cancer are reported.
It is also estimated that over a million cases of epidermoid carcinoma are diagnosed annually. This data is for the United States only. Just imagine what the worldwide numbers would look like.
(day care and night care)
(day care and night care)
To be completed: by 2022.
ALREADY UNDER DEVELOPMENT!